What’s the next step after losing weight with GLP-1s? | The campaign is one of weight loss app Noom's largest brand investment to date and features two TV spots and new in-app features with its chief wellness officer Rebel Wilson.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
As the new Chief Wellness Amassador at Noom, a weight loss platform, Rebel Wilson is endorsing their GLP-1 'microdosing' campaign.
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward…
Weight loss company Noom is offering an at-home biomarker testing kit for its U.S. members, expanding its platform into…
Virtual care platform First Stop Health unveiled an expansion of its Healthy Weight Program amid increasing GLP-1 demand and…
For Novo Nordisk, the launch of the company’s highly anticipated Wegovy pill at the start of the year—representing the first oral…
A new startup is making a bold move in the world of obesity drug development: It’s not working with the GLP-1 target that has…
